In addition, a meta‐analysis according to recently published randomized controlled trials (RCTs) was also conducted to further evaluate the relationship between liver metastases and the efficacy of anti‐PD‐1‐chemotherapy combinations as the first‐line treatment in advanced ESCC patients. Here, PDCD1 is linked to esophageal squamous cell carcinoma.